1. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM,
et al. CDC growth charts: United States. Adv Data.
2000;(314):1-27.
2. Clementi M, Milani S, Mammi I, Boni S, Monciotti C, Tenconi
R. Neurofibromatosis type 1 growth charts. Am J Med Genet.
1999;87(4):317-323.
3. Pang T, Atefy R, Sheen V. Malformations of cortical development. Neurologist.
2008;14(3):181-191.
4. Cole TR, Hughes HE. Autosomal dominant macrocephaly: benign
familial macrocephaly or a new syndrome? Am J Med Genet.
1991;41(1):115-124.
5. Asch AJ, Myers GJ. Benign familial macrocephaly: report of
a family and review of the literature. Pediatrics.
1976;57(4):535-539.
6. Bennett MR, Rizvi TA, Karyala S, McKinnon RD, Ratner N. Aberrant
growth and differentiation of oligodendrocyte progenitors in neurofibromatosis
type 1 mutants. J Neurosci. 2003;23(18):7207-7217.
7. Fidler DJ, Bailey JN, Smalley SL. Macrocephaly in autism
and other pervasive developmental disorders. Dev Med Child
Neurol. 2000;42(11):737-740.
8. Baujat G, Cormier-Daire V. Sotos syndrome.
Orphanet
J Rare Dis. 2007;2:36.
[PubMed: 17825104]
9. Aoki N, Oikawa A, Sakai T. Serial neuroimaging studies in
Sotos syndrome (cerebral gigantism syndrome). Neurol Res.
1998;20(2):149-152.
10. Cytrynbaum CS, Smith AC, Rubin T, Weksberg R. Advances in
overgrowth syndromes: clinical classification to molecular delineation
in Sotos syndrome and Beckwith-Wiedemann syndrome. Curr
Opin Pediatr. 2005;17(6):740-746.
11. Williams CA, Dagli A, Battaglia A. Genetic disorders associated
with macrocephaly. Am J Med Genet A. 2008;146A:2023-2037.
12. Pridmore CL, Baraitser M, Harding B, Boyd SG, Kendall B, Brett
EM. Alexander’s disease: clues to diagnosis. J
Child Neurol. 1993;8(2):134-144.
13. Surendran S, Michals-Matalon K, Quast MJ, et al. Canavan
disease: a monogenic trait with complex genomic interaction. Mol
Genet Metab. Sep-Oct 2003;80(1-2):74-80.
14. Giugliani R, Dutra JC, Pereira ML, et al. GM1 gangliosidosis: clinical
and laboratory findings in eight families. Hum Genet.
1985;70(4):347-354.
15. Woods CG. Human microcephaly. Curr Opin Neurobiol.
2004;14(1):112-117.
16. Abuelo D. Microcephaly syndromes. Semin Pediatr
Neurol. 2007;14(3):118-127.
17. Guerrini R, Marini C. Genetic malformations of cortical
development.
Exp Brain Res. 2006; 173(2):322-333.
[PubMed: 16724181]
18. Degani S. Sonographic findings in fetal viral infections:
a systematic review. Obstet Gynecol Surv. 2006;61(5):329-336.
19. Singer LT, Salvator A, Arendt R, Minnes S, Farkas K, Kliegman R.
Effects of cocaine/polydrug exposure and maternal psychological distress
on infant birth outcomes. Neurotoxicol Teratol.
2002;24(2):127-135.
20. Pennell PB. Pregnancy in the woman with epilepsy: maternal and
fetal outcomes. Semin Neurol. 2002;22(3):299-308.
21. Curry CJ, Bhullar S, Holmes J, Delozier CD, Roeder ER, Hutchison
HT. Risk factors for perinatal arterial stroke: a study of 60 mother-child
pairs. Pediatr Neurol. 2007;37(2):99-107.
22. Rouse B, Matalon R, Koch R, et al. Maternal phenylketonuria syndrome:
congenital heart defects, microcephaly, and developmental outcomes. J
Pediatr. 2000;136(1):57-61.
23. Dolk H. The predictive value of microcephaly during the
first year of life for mental retardation at seven years. Dev
Med Child Neurol. 1991;33(11):974-983.
24. Custer DA, Vezina LG, Vaught DR, et al. Neurodevelopmental
and neuroimaging correlates in nonsyndromal microcephalic children. J
Dev Behav Pediatr. 2000;21(1):12-18.
25. Battaglia A. Neuroimaging studies in the evaluation of developmental
delay/mental retardation. Am J Med Genet C Semin
Med Genet. 15 2003;117C(1):25-30.